drugset / Trial / NCT00002326

The Safety and Effectiveness of Zidovudine Plus Adefovir in HIV-Infected Patients

NCT00002326

Phase 1 Completed 20 enrolled Gilead Sciences
Treatment

Summary

To study the safety, tolerance, pharmacokinetics, and anti-HIV effects of combination zidovudine (AZT) and PMEA (adefovir) therapy.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Adefovir Unknown Intravenous
Subject Zidovudine Small molecule